Company / Cash per Share
Vaxcyte, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.28
FY2025
5-year range
$1.28 / $12.87
FY2021-FY2025
Trend
-59.8%
vs FY2024
Sector context
#136 of 205
Health Care
What the data says
At $1.28, Vaxcyte, Inc.'s cash per share ranks #136 of 205 in the Health Care sector. Cash per Share has declined for 3 consecutive years, from $12.87 in FY2022 to $1.28 in FY2025.
Based on SEC 10-K filings.
1.28 in FY2025 with a 5-year CAGR of -37.2%.
Declined from $4.09 to $1.28 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -53.7%
- 5-Year CAGR
- -37.2%
- 10-Year CAGR
- -
Sector benchmark
#136 of 205 in Health CareTop 66% of 205This company $1.28 Sector average $72.93
▼
-98.2% below sector average
Key checks
Key Insights
- Vaxcyte, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 59.8% year-over-year.
- Ranks #136 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.28 | -59.8% |
| FY2024 | $3.18 | -22.3% |
| FY2023 | $4.09 | -68.2% |
| FY2022 | $12.87 | +868.3% |
| FY2021 | $1.33 | -89.8% |
| FY2020 | $13.07 | -15.9% |
| FY2019 | $15.54 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026